Search result : 13 product found

Refine your search :

RUOCE / IVD

Unconjugated 5

Inhibitor/Antagonist/Agonist 5
Biological fluids 4
Buffers and reagents 4

human 2

APPLY FILTERS
REINITIALIZE

Cat#

Description

Cond.

Price Bef. VAT

orb1910402-250mg

DS79932728 is a Potent, Orally Available G9a/GLP Inhibitor for Treating β‑Thalassemia and Sickle Cell Disease.

250mg

orb1910402-1g

DS79932728 is a Potent, Orally Available G9a/GLP Inhibitor for Treating β‑Thalassemia and Sickle Cell Disease.

orb1910402-100mg

DS79932728 is a Potent, Orally Available G9a/GLP Inhibitor for Treating β‑Thalassemia and Sickle Cell Disease.

100mg

orb1911012-250mg

Pociredir is an embryonic ectoderm development (EED) protein inhibitor. Pociredir can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease. [[2490674-02-5]]

250mg

orb1911012-100mg

Pociredir is an embryonic ectoderm development (EED) protein inhibitor. Pociredir can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease. [[2490674-02-5]]

100mg

MBS8421629

Single Donor Human Sickle Cell Serum

onrequest

MBS8421086

Single Donor Human Sickle Cell Plasma

onrequest

691611-LU

Sickle Cell Positive Control 1 mL

1mL

691601-LU

Sickle Cell Negative Control 1 mL

1mL

691600-LU

SICKLE CELL NEGATIVE CONTROL, FILLED VIAL (BULK)

0.5mL

691610-LU

SICKLE CELL POSITIVE CONTROL, FILLED VIAL (BULK)

0.5mL

B2014024

Single Donor Human Sickle Cell Serum

1mL

B2014427

Single Donor Human Sickle Cell Plasma

1mL

‹

›